Cathepsin L, target in cancer treatment? - PubMed (original) (raw)
Review
. 2010 Feb 13;86(7-8):225-33.
doi: 10.1016/j.lfs.2009.11.016. Epub 2009 Nov 30.
Affiliations
- PMID: 19958782
- DOI: 10.1016/j.lfs.2009.11.016
Review
Cathepsin L, target in cancer treatment?
Jacqueline M Lankelma et al. Life Sci. 2010.
Abstract
Cathepsin L, a cysteine protease, is considered to be a potential therapeutic target in cancer treatment. Proteases are involved in the development and progression of cancer. Inhibition of activity of specific proteases may slow down cancer progression. In this review, we evaluate recent studies on the inhibition of cathepsin L in cancer. The effects of cathepsin L inhibition as a monotherapy on apoptosis and angiogenesis in cancer are ambiguous. Cathepsin L inhibition seems to reduce invasion and metastasis, but there is concern that selective cathepsin L inhibition induces compensatory activity by other cathepsins. The combination of cathepsin L inhibition with conventional chemotherapy seems to be more promising and has yielded more consistent results. Future research should be focused on the mechanisms and effects of this combination therapy.
Copyright 2009 Elsevier Inc. All rights reserved.
Similar articles
- Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
Yuan L, Sheng L, He W, Zou C, Hu B, Liu J, Ge W, Liu Y, Wang J, Ma E. Yuan L, et al. Bioorg Chem. 2018 Dec;81:672-680. doi: 10.1016/j.bioorg.2018.09.029. Epub 2018 Sep 20. Bioorg Chem. 2018. PMID: 30253340 - Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Parker EN, Song J, Kishore Kumar GD, Odutola SO, Chavarria GE, Charlton-Sevcik AK, Strecker TE, Barnes AL, Sudhan DR, Wittenborn TR, Siemann DW, Horsman MR, Chaplin DJ, Trawick ML, Pinney KG. Parker EN, et al. Bioorg Med Chem. 2015 Nov 1;23(21):6974-92. doi: 10.1016/j.bmc.2015.09.036. Epub 2015 Sep 25. Bioorg Med Chem. 2015. PMID: 26462052 Free PMC article. - [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA, Korolenko TA, Il'nitskaia SI. Khalikova TA, et al. Biomed Khim. 2009 Sep-Oct;55(5):621-34. Biomed Khim. 2009. PMID: 20017393 Russian. - Cathepsin B and L inhibitors: a patent review (2010 - present).
Li YY, Fang J, Ao GZ. Li YY, et al. Expert Opin Ther Pat. 2017 Jun;27(6):643-656. doi: 10.1080/13543776.2017.1272572. Epub 2016 Dec 23. Expert Opin Ther Pat. 2017. PMID: 27998201 Review. - Cathepsin L targeting in cancer treatment.
Sudhan DR, Siemann DW. Sudhan DR, et al. Pharmacol Ther. 2015 Nov;155:105-16. doi: 10.1016/j.pharmthera.2015.08.007. Epub 2015 Aug 20. Pharmacol Ther. 2015. PMID: 26299995 Free PMC article. Review.
Cited by
- Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer.
Brindle NR, Joyce JA, Rostker F, Lawlor ER, Swigart-Brown L, Evan G, Hanahan D, Shchors K. Brindle NR, et al. PLoS One. 2015 Apr 30;10(4):e0120348. doi: 10.1371/journal.pone.0120348. eCollection 2015. PLoS One. 2015. PMID: 25927437 Free PMC article. - BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells.
Grotsky DA, Gonzalez-Suarez I, Novell A, Neumann MA, Yaddanapudi SC, Croke M, Martinez-Alonso M, Redwood AB, Ortega-Martinez S, Feng Z, Lerma E, Ramon y Cajal T, Zhang J, Matias-Guiu X, Dusso A, Gonzalo S. Grotsky DA, et al. J Cell Biol. 2013 Jan 21;200(2):187-202. doi: 10.1083/jcb.201204053. J Cell Biol. 2013. PMID: 23337117 Free PMC article. - Cathepsin L induces cellular senescence by upregulating CUX1 and p16INK4a.
Wu Y, Jiang D, Liu Q, Yan S, Liu X, Wu T, Sun W, Li G. Wu Y, et al. Aging (Albany NY). 2024 Jun 18;16(13):10749-10764. doi: 10.18632/aging.205955. Epub 2024 Jun 18. Aging (Albany NY). 2024. PMID: 38944813 Free PMC article. - Localization patterns of cathepsins K and X and their predictive value in glioblastoma.
Breznik B, Limback C, Porcnik A, Blejec A, Krajnc MK, Bosnjak R, Kos J, Van Noorden CJF, Lah TT. Breznik B, et al. Radiol Oncol. 2018 Oct 18;52(4):433-442. doi: 10.2478/raon-2018-0040. Radiol Oncol. 2018. PMID: 30367810 Free PMC article. - Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer.
Tian Y, Bova GS, Zhang H. Tian Y, et al. Anal Chem. 2011 Sep 15;83(18):7013-9. doi: 10.1021/ac200815q. Epub 2011 Aug 18. Anal Chem. 2011. PMID: 21780747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources